CorMedix (CRMD) Misses Q2 EPS by 2c

CorMedix (NYSE: CRMD) reported Q2 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.51 million, versus $119.97 million reported last year.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Taylor Devices (TAYD) Misses Q4 EPS by 31c